ASU's 'morning after' pill sales generate controversy
16th Nov 2006, 22:04 GMT
Arizona State University is facing criticism for selling the Plan B "morning after" pill at its campus pharmacies and health centers. The drug prevents pregnancies by keeping fertilized eggs from implanting on a woman's uterus
Latest news from bizjournals.com Health Care:Pharmaceuticals headlines:
- Spectrum Pharmaceuticals gets $5M milestone payment, settles with GlaxoSmithKline
- Corautus Genetics chips at Q3 loss
- Spherix hoping to brush its sweet tooth
- Auxilium added to NASDAQ's biotech index
- CombinatoRx reports revenue boost
- Alexion gets fast-track FDA review for drug Soliris
- InnoCentive identifies a new CEO
- Digene names new CEO
- Dynamic Health dips into the red
- Sigma-Aldrich elects Paul to board